Juul’s San Francisco Headquarters May Be Sold as Debt Talks Advance

Oct.23.2025
Juul’s San Francisco Headquarters May Be Sold as Debt Talks Advance
Real estate firm Affinius Capital is in talks to sell the loan tied to Juul’s San Francisco headquarters, with Madison Capital emerging as a potential buyer. If completed, the deal could lead to a change in ownership six years after Juul first acquired the building, signaling continued asset adjustments amid regulatory pressure.

Key Points:

 

  • Affinius Capital is negotiating the sale of debt linked to Juul’s 123 Mission Street office building.

 

  • Madison Capital may acquire the property if the debt is classified as non-performing.

 

  • Juul bought the 29-story building in 2019 for $397 million but moved its headquarters to Washington, D.C. in 2020.

 

  • Previous sale attempts with PGIM and PIMCO fell through; the new deal may come at a discounted valuation.

 


 

According to the San Francisco Business Times, real estate investment firm Affinius Capital is planning to sell the loan associated with Juul Labs’ headquarters at 123 Mission Street in San Francisco. U.S. private equity and real estate firm Madison Capital is reportedly the leading contender to purchase the debt. If the transaction goes through, the 29-story tower could change hands six years after Juul acquired it.

 

旧金山米申街 123 号
Juul’s San Francisco Headquarters | Image source: Mingtiandi

 

Sources say the deal has not yet been finalized. Should the debt be deemed non-performing, Madison Capital could take ownership of the property through foreclosure or a negotiated transfer.

 

Juul purchased the 387,000-square-foot building in June 2019 for $397 million to accommodate its expanding workforce. However, the company’s valuation fell sharply following heightened regulatory scrutiny of its vaping products, prompting significant staff reductions.

 

In May 2020, Juul announced the relocation of its headquarters to Washington, D.C. and listed the San Francisco property for sale. Multiple sale attempts, including deals with PGIM and PIMCO, collapsed that year. Madison Capital, which had previously partnered with PGIM in a bid for the building, may now pursue the property again—likely at a discounted price from the pre-pandemic valuation of roughly $1,100 per square foot, or about $400 million.

 

Affinius Capital (formerly Square Mile Capital) provided a $220 million loan for Juul’s original purchase of the property. The firm has since scaled back its San Francisco holdings, selling One Montgomery and acquiring debt on 600 Battery Street.

Juul’s efforts to lease out portions of the Mission Street tower have also failed to gain traction.

 

Canada: “I Want My Pouches” launches during National Non-Smoking Week to push easier adult access to nicotine pouches
Canada: “I Want My Pouches” launches during National Non-Smoking Week to push easier adult access to nicotine pouches
Canadian consumer advocacy group I Want My Pouches announced its launch during National Non-Smoking Week, calling for straightforward, consistent and practical adult access to nicotine pouches.
Jan.22 by 2FIRSTS.ai
Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
A Thai report says Minister attached to the Prime Minister’s Office Santi Piyatat is advancing efforts toward a vape-free society. On Jan. 12, a seminar at the Thai Health Promotion Foundation’s learning center presented a study covering six regions of Thailand on spending related to cigarettes and e-cigarettes and the behavior of different smoker groups.
Jan.13 by 2FIRSTS.ai
UK South East Seized 3.1M Illegal Vapes Since 2021 as Crackdown Intensifies
UK South East Seized 3.1M Illegal Vapes Since 2021 as Crackdown Intensifies
Illegal vape seizures in the UK South East have risen sharply over the past five years, with 2023 marking the high point. While single-use vapes were banned from sale in June 2025, enforcement teams say disposable products remain in circulation, fueling renewed calls for licensing and stronger enforcement funding.
Jan.23 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11